OBJECTIVES: Gastric conduit cancer (GCC), which is a carcinoma that arises in the gastric conduit after oesophagectomy, often negatively affects long-term survivors of oesophageal cancer. The aim of this study was to evaluate the incidence and clinical implications of GCC.
INTRODUCTION
Gastric conduit cancer (GCC) is defined as a newly developed gastric cancer in the gastric conduit used as an oesophageal substitute after oesophagectomy [1, 2] . The GCC incidence has increased in recent years as advances in oesophageal cancer treatment have contributed to the prolongation of patient survival. GCC often markedly affects the survival and well being of long-term survivors of oesophageal cancer, and the presence of GCC often presents physicians with a difficult therapeutic decision. However, little information about GCC is available. Accordingly, we reviewed our experiences to evaluate the incidence, interval between oesophagectomy and GCC detection and clinicopathological features of GCC, and to clarify the optimal approach for GCC management in patients who underwent curative surgery for oesophageal cancer.
MATERIALS AND METHODS
From a prospectively entered database, which contained findings for 964 patients who underwent surgery for oesophageal cancer at Asan Medical Center between May 1993 and November 2011, 101 patients were excluded from the present study because nongastric conduits (81 colonic conduit, 19 jejunal conduit and 1 jejunal and colonic conduit) were used for reconstruction after oesophagectomy. Consequently, 863 patients who underwent oesophagectomy and reconstruction with the gastric conduit were selected as the main study group for analysis. Oesophagectomy with reconstruction was performed by using the Ivor Lewis procedure (median laparotomy and right transthoracic oesophagectomy with reconstruction) in 617 patients, the McKeown procedure (right thoracotomy, median laparotomy and left cervical oesophagectomy with reconstruction) in 202 patients, the transhiatal approach in 38 patients and in the remaining 6 patients, other procedures were performed. A narrow gastric tube was used for reconstruction in almost all patients, either a pyloroplasty or a finger fracture of the pyloric muscle was performed for gastric drainage.
The data of these 863 patients was reviewed retrospectively to determine the occurrence of GCC. The clinicopathological data of GCC, including symptoms, diagnostic tools, interval between surgery for oesophageal cancer and detection of GCC, treatment modalities and clinical outcomes were analysed. This study was approved by our institutional Ethics Committee/Review Board, which waived the requirement for informed patient consent because of the retrospective nature of the analyses.
To describe the location of the GCC, we divided the gastric conduit into four regions according to the native gastric anatomy: the anastomosis site, body, antrum and pylorus of the gastric conduit. The cancer staging for both the oesophageal cancer and the gastric cancer was based on the seventh edition of the American Joint Committee on Cancer (AJCC) staging manual. Kaplan-Meier curves were used to delineate the survival rate, and log-rank tests were used to compare the between-group differences in the rates. Statistical analyses were performed with SPSS 18.0 (IBM, New York, NY, USA), and a P-value of <0.05 was regarded as significant.
RESULTS
A total of 18 cases of GCC in 18 patients were identified, with a median follow-up of 34 months (range, 0-203 months). The cumulative incidence rates of GCC were 2.4% at 5 years and 5.7% at 10 years ( Fig. 1 ). All patients were male and all cases of oesophageal cancer were of squamous cell carcinoma. The median age of the patients at the time of oesophagectomy was 60.0 years (range, 39-74). The median interval between surgery for oesophageal cancer and detection of GCC was 5.0 years (range, 1-16). The median age of the patients at the time of GCC detection was 64 years (range, 45-75). Ten patients were asymptomatic and the GCC was incidentally detected by periodic endoscopy. All cases of GCC were of adenocarcinoma and 12 were located on the antrum of the gastric tube (Table 1) .
For treatment of the 18 GCCs, endoscopic submucosal dissection (ESD) was performed in 6 patients, total gastric conduit gastrectomy with colon interposition was performed in 3 patients, including 2 patients who underwent prior ESD, and chemotherapy was performed in 6 patients. Five patients received conservative Figure 1 : The cumulative incidence curve of GCC estimated by the KaplanMeier method. Cumulative incidence rates of GCC were 2.4% at 5 years and 5.7% at 10 years. GCC: gastric conduit cancer; OC: oesophageal cancer. treatment alone. Of the 6 patients who underwent ESD, 5 had no complications ( Table 2 ). Microperforation occurred in 1 patient who underwent ESD in an outside hospital and underwent surgery at our institution. Of the 5 patients who underwent ESD in our hospital, complete resection was achieved in four patients. One patient who showed a positive resection margin received salvage radiation therapy and chemotherapy. During follow-up, recurrence was found in 1 of the patients who underwent ESD 20 months afterwards; this patient underwent surgery for recurred GCC.
Surgical treatment was performed in 3 patients (Table 3) . One patient underwent a total gastric conduit gastrectomy with colon interposition through the posterior mediastinal route before the use of the ESD technique was common. Another patient underwent a total gastric conduit gastrectomy with colon interposition for recurrent GCC after a prior ESD. The last patient underwent a total gastric conduit gastrectomy with colon interposition through the retrosternal route due to perforation after ESD. This patient died 13 months after the operation due to acute respiratory distress syndrome caused by pneumonia.
The median survival of the 18 patients after the diagnosis of GCC was 7.5 months (range, 1-118). The 5-year survival rate of all patients was 22.2% (Fig. 2) . The 3-year survival rates of the patients who underwent ESD, total gastric conduit gastrectomy with colon interposition and chemotherapy or conservative treatment were 100, 50 and 9.1%, respectively (P = 0.003).
DISCUSSION
The overall incidence of carcinoma in the gastric conduit used for oesophageal substitution has been reported in the literature to be between 1.5 and 8.6% [2] [3] [4] [5] [6] . In accordance with previous studies, our results found a 10-year cumulative incidence rate of GCC of 5.7%. The incidence of GCC is relatively low; however, the risk of GCC will become one of the major prognostic factors for long-term survival after curative resection for oesophageal cancer because cancer in the gastric conduit is increasingly being reported due to the increased survival of oesophageal cancer patients [3] .
Interestingly, almost all current reports on GCC come from Asia including Japan, China, Hong Kong and Korea [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . We speculated that there is a very close relationship with the high gastric cancer incidence rates of these countries. The incidence rates ( per 100 000) of gastric cancer vary to 65.9 in men and 25.9 women in Korea. These large regional variations could reflect differences in prevalence of Helicobacter pylori infection, which accounts for >60% of gastric cancer worldwide. Differences in smoking prevalence may also, in part, contribute to this variation because it accounts for 10% of all stomach cancers worldwide [11] .
The pathogenesis of GCC could be discussed from several viewpoints which imply a cancerous multiplicity and postoesophagectomy structural changes. A cancerous multiplicity associated with oesophageal cancer may play a role in the development of GCC and could be explained by the concept of 'field cancerization', in which exposure of the epithelium of the head-and-neck, oesophagus and lung to a common carcinogen leads to multiple carcinomas [12] . The structural changes after oesophagectomy in relation to the reconstruction with gastric conduit and pyroloplasty, which could make a duodenogastric reflux with bile contents.
In the similar context, possible risk factors of GCC include H. pylori infection, prior radiation therapy and long-term bile reflux into gastric conduit [10] . H. pylori infection may contribute to the carcinogenic effect of gastric cancer by causing chronic gastritis, loss of gastric acidity and bacterial growth in the stomach. Some studies in the literature have reported that H. pylori eradication decreases the incidence and recurrence of ordinary gastric cancer [13] and prophylactic eradication of H. pylori after endoscopic resection of early gastric cancer, is used to prevent the development of metachronous gastric carcinoma [14] . These articles imply that H. pylori eradication could be helpful to prevent GCC in patients who undergo oesophagectomy and have reconstruction by using gastric conduit for oesophageal cancer. In regard to the effect of prior radiation therapy, there was no apparent evidence of the influence of radiation therapy in the development of secondary gastric carcinoma. However, Sugiura et al. [3] recommended that the oesophageal substitute can be shielded from the irradiation field when postoperative radiation therapy is proposed, because the influence of radiation must be reduced as much as possible. Meanwhile, long-term bile reflux into gastric mucosa is known as an important trigger for the development of intestinal metaplasia and suggests that bile reflux plays an important role in the development of GCC [1, 2, 15] . While gastric drainage procedures may facilitate gastric emptying and thus reduce gastro-oesophageal reflux, it could promote duodenogastric reflux. Future investigations will be required to ascertain the effects of H. pylori infection, prior radiation therapy and gastric drainage procedure for development of GCC in patients who undergo oesophagectomy and have reconstruction by using gastric conduit. More than half of the patients diagnosed with GCC in the present study were asymptomatic and were incidentally diagnosed under periodic upper gastrointestinal endoscopy. This result indicates that periodic endoscopic follow-up is essential in patients who underwent a reconstruction using a gastric conduit after oesophagectomy for oesophageal cancer. However, the optimal duration and interval of endoscopic surveillance has not been established. As shown in Fig. 1 , the cumulative incidence curve of GCC was generally linear up to 10 years, suggesting that the incidence is constant up to 10 years. This result is in close agreement with that of a previous article in which it was reported that GCC had a constant risk of occurrence and that the 10-year cumulative incidence rate was 8.1% [2] . These results suggest that patients should be under surveillance for 10 years after oesophagectomy for oesophageal cancer to detect metachronous GCC. With regard to the periodic endoscopy interval, Nakajima et al. [16] reported that an annual endoscopic surveillance programme is effective in order to detect metachronous gastric cancer at a stage early enough for a curative repeat endoscopic resection in patients who underwent endoscopic resection for early gastric cancer. Most of the authors dealing with GCC, recommend annual endoscopic examination in patients using gastric conduit after oesophagectomy for oesophageal cancer [2] [3] [4] 6] . Many of the recent reports highlight the values of endoscopic resection as a minimally invasive treatment, which includes endoscopic mucosal dissection (EMR) and ESD for good clinical outcomes in patients diagnosed with early GCC [2] [3] [4] [5] [6] 9] . Compared with conventional EMR procedures, ESD has several advantages including the potential to achieve a higher complete resection rate [16] . Among the articles dealing with ESD in a gastric conduit, complete resection rate was reported as 88-95% [2, 5, 17] . Performing ESD in a gastric conduit is considered a technically demanding procedure due to the influence of fibrosis and deformity due to the previous surgery and the higher complication rate of a perforation [17] . To prevent fatal complications including acute mediastinitis or peritonitis, rapid treatments including intravenous fluid and antibiotics therapies are essential [5] .
Surgical resection is not usually preferred because of its high morbidity and mortality [3] . However, periodic endoscopy does not always guarantee early detection or complete resection for GCC, and thus surgical treatment for GCC is sometimes essential. For the surgical treatment for GCC, gastric conduit gastrectomy with total or partial resection of the gastric conduit is proposed. For the partial resection of the gastric conduit, careful dissection to preserve the right gastroepiploic artery is mandatory to maintain adequate blood supply to the residual gastric conduit. In addition, it is important to endoscopically confirm the tumour location and clip at the tumour before surgery, for the surgical margin to be free from cancer following surgery [4] . For the total resection of the gastric conduit, an interruption of the blood supply to the gastric conduit is necessary, because this procedure would reduce intraoperative blood loss and postoperative complications [18] . Additionally, substitutes such as colon or jejunum should be prepared for the oesophageal reconstruction after the total resection of gastric conduit.
The prognosis of GCC has been regarded as poor because many cases of GCC are found at the advanced stage [3] . Our present results show that the overall 5-year survival rate of patients was 23.8%. In particular, patients who were treated with palliative treatment due to the advanced stage of the GCC had a very poor prognosis. However, endoscopic resection as a minimally invasive treatment or surgical gastrectomy for early GTC showed a favourable outcome compared with chemotherapy or conservative treatment for advanced GCC. This result reaffirms the importance of early detection of GCC for good clinical outcomes in patients with a gastric conduit after oesophagectomy for oesophageal cancer.
This study is subject to the limitations inherent in retrospective work with observation data collected at a specific time point. It also represents the experience of a single tertiary referral centre and might not be generalized. The pathophysiology of GCC still remains unclear because possible risk factors for GCC, such as H. pylori infection, bile reflux and radiation therapy, could not be estimated in this study. This lack of clarity merits a future study that analyses the pathophysiology of GCC and how to prevent GCC occurrence.
In summary, patients had a constant risk of GCC occurrence after oesophagectomy for oesophageal cancer. Endoscopic or surgical resection for early GCC shows favourable outcomes compared with chemotherapy or conservative treatment for advanced GCC. A regular and long-term follow-up including detailed endoscopy is essential for the early detection of GCC in patients with a gastric conduit after oesophagectomy for oesophageal cancer.
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